Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2025-05-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$153.7m reported value -1.0% vs Q4 2024
36positions
69.2%in top 10
4 new 2 added 1 reduced 3 sold out vs Q4 2024

Holdings, Q1 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 5,475,516 $31.5m20.48% 20.48% UnchangedShares held: Q2 2024 5.5m, Q3 2024 5.5m, Q4 2024 5.5m, Q1 2025 5.5m
2 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 830,879 $20.0m12.99% 12.99% AddedShares held: Q2 2024 710.4k, Q3 2024 710.4k, Q4 2024 760.4k, Q1 2025 830.9k +70.5k +70,457 9.3%
3 ENTERA BIO LTD SHS ENTX ENTX 5,881,879 $10.0m6.50% 6.50% UnchangedShares held: Q2 2024 3.9m, Q3 2024 3.9m, Q4 2024 5.9m, Q1 2025 5.9m
4 SPDR GOLD TR GOLD SHS GLD GLD 32,000 $9.2m6.00% 6.00% UnchangedShares held: Q2 2024 32.0k, Q3 2024 32.0k, Q4 2024 32.0k, Q1 2025 32.0k
5 MEIRAGTX HLDGS PLC COM MGTX MGTX 1,250,000 $8.5m5.51% 5.51% UnchangedShares held: Q2 2024 0, Q3 2024 1.2m, Q4 2024 1.2m, Q1 2025 1.2m
6 AGNICO EAGLE MINES LTD COM AEM AEM 55,500 $6.0m3.91% 3.91% UnchangedShares held: Q2 2024 55.5k, Q3 2024 55.5k, Q4 2024 55.5k, Q1 2025 55.5k
7 ALTIMMUNE INC COM NEW ALT ALT 1,121,524 $5.6m3.65% 3.65% UnchangedShares held: Q2 2024 1.1m, Q3 2024 1.1m, Q4 2024 1.1m, Q1 2025 1.1m
8 KINROSS GOLD CORP COM KGC KGC 440,000 $5.5m3.61% 3.61% UnchangedShares held: Q2 2024 440.0k, Q3 2024 440.0k, Q4 2024 440.0k, Q1 2025 440.0k
9 SANDSTORM GOLD LTD COM NEW SSL SSL 700,000 $5.3m3.44% 3.44% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 700.0k
10 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 600,000 $4.7m3.06% 3.06% UnchangedShares held: Q2 2024 600.0k, Q3 2024 600.0k, Q4 2024 600.0k, Q1 2025 600.0k
11 OCULAR THERAPEUTIX INC COM OCUL OCUL 600,400 $4.4m2.86% 2.86% UnchangedShares held: Q2 2024 200.4k, Q3 2024 600.4k, Q4 2024 600.4k, Q1 2025 600.4k
12 FRANCO NEV CORP COM FNV FNV 25,000 $3.9m2.56% 2.56% UnchangedShares held: Q2 2024 25.0k, Q3 2024 25.0k, Q4 2024 25.0k, Q1 2025 25.0k
13 ELICIO THERAPEUTICS INC COM ELTX ELTX 630,915 $3.9m2.53% 2.53% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 630.9k
14 APPLIED THERAPEUTICS INC COM APLT APLT 7,799,687 $3.8m2.48% 2.48% AddedShares held: Q2 2024 5.6m, Q3 2024 5.6m, Q4 2024 5.8m, Q1 2025 7.8m +2.0m +2,000,000 34.5%
15 EQUINOX GOLD CORP COM EQX EQX 550,811 $3.8m2.47% 2.47% UnchangedShares held: Q2 2024 550.8k, Q3 2024 550.8k, Q4 2024 550.8k, Q1 2025 550.8k
16 SEABRIDGE GOLD INC COM COM 317,003 $3.7m2.41% 2.41% UnchangedShares held: Q2 2024 246.6k, Q3 2024 317.0k, Q4 2024 317.0k, Q1 2025 317.0k
17 SKEENA RES LTD NEW COM SKE SKE 315,400 $3.2m2.07% 2.07% UnchangedShares held: Q2 2024 38.8k, Q3 2024 315.4k, Q4 2024 315.4k, Q1 2025 315.4k
18 MAG SILVER CORP COM MAG MAG 170,000 $2.6m1.69% 1.69% UnchangedShares held: Q2 2024 275.0k, Q3 2024 170.0k, Q4 2024 170.0k, Q1 2025 170.0k
19 ISHARES SILVER TR ISHARES SLV SLV 80,000 $2.5m1.61% 1.61% UnchangedShares held: Q2 2024 48.5k, Q3 2024 80.0k, Q4 2024 80.0k, Q1 2025 80.0k
20 NUVATION BIO INC COM CL A NUVB NUVB 1,025,000 $1.8m1.17% 1.17% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 1.0m
21 VISA INC COM CL A V V 4,850 $1.7m1.11% 1.11% UnchangedShares held: Q2 2024 4.8k, Q3 2024 4.8k, Q4 2024 4.8k, Q1 2025 4.8k
22 PHILIP MORRIS INTL INC COM PM PM 10,000 $1.6m1.03% 1.03% UnchangedShares held: Q2 2024 10.0k, Q3 2024 10.0k, Q4 2024 10.0k, Q1 2025 10.0k
23 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $1.4m0.88% 0.88% UnchangedShares held: Q2 2024 13.0k, Q3 2024 13.0k, Q4 2024 13.0k, Q1 2025 13.0k
24 ROYAL GOLD INC COM RGLD RGLD 7,550 $1.2m0.80% 0.80% UnchangedShares held: Q2 2024 7.5k, Q3 2024 7.5k, Q4 2024 7.5k, Q1 2025 7.5k
25 ISHARES TR US AER DEF ETF ITA ITA 7,650 $1.2m0.76% 0.76% UnchangedShares held: Q2 2024 7.7k, Q3 2024 7.7k, Q4 2024 7.7k, Q1 2025 7.7k
26 NORTHROP GRUMMAN CORP COM NOC NOC 2,165 $1.1m0.72% 0.72% UnchangedShares held: Q2 2024 2.2k, Q3 2024 2.2k, Q4 2024 2.2k, Q1 2025 2.2k
27 ALAMOS GOLD INC NEW COM CL A AGI AGI 41,000 $1.1m0.71% 0.71% UnchangedShares held: Q2 2024 80.0k, Q3 2024 41.0k, Q4 2024 41.0k, Q1 2025 41.0k
28 WHEATON PRECIOUS METALS CORP COM WPM WPM 12,500 $970.4k0.63% 0.63% UnchangedShares held: Q2 2024 60.0k, Q3 2024 12.5k, Q4 2024 12.5k, Q1 2025 12.5k
29 DIAGEO PLC SPON ADR NEW DEO DEO 6,750 $707.3k0.46% 0.46% UnchangedShares held: Q2 2024 6.8k, Q3 2024 6.8k, Q4 2024 6.8k, Q1 2025 6.8k
30 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 260,470 $586.1k0.38% 0.38% UnchangedShares held: Q2 2024 260.5k, Q3 2024 260.5k, Q4 2024 260.5k, Q1 2025 260.5k
31 COEUR MNG INC COM NEW CDE CDE 96,132 $569.1k0.37% 0.37% NewShares held: Q2 2024 0, Q3 2024 0, Q4 2024 0, Q1 2025 96.1k
32 HOOKIPA PHARMA INC COM COM 498,625 $538.5k0.35% 0.35% UnchangedShares held: Q2 2024 5.5m, Q3 2024 551.7k, Q4 2024 498.6k, Q1 2025 498.6k
33 NEW PAC METALS CORP COM NEWP NEWP 485,000 $535.9k0.35% 0.35% UnchangedShares held: Q2 2024 485.0k, Q3 2024 485.0k, Q4 2024 485.0k, Q1 2025 485.0k
34 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 7,049 $447.5k0.29% 0.29% ReducedShares held: Q2 2024 200.0k, Q3 2024 200.0k, Q4 2024 200.0k, Q1 2025 7.0k -193.0k -192,951 -96.5%
35 Orgenesis, Inc. COM COM 50,623 $124.0k0.08% 0.08% UnchangedShares held: Q2 2024 634.7k, Q3 2024 63.5k, Q4 2024 50.6k, Q1 2025 50.6k
36 CARDIOL THERAPEUTICS INC COM CL A CRDL CRDL 100,000 $96.9k0.06% 0.06% UnchangedShares held: Q2 2024 100.0k, Q3 2024 100.0k, Q4 2024 100.0k, Q1 2025 100.0k

Sold out since Q4 2024

SecurityTickerShares held beforeValue then
SILVERCREST METALS INC SIL SIL 60,000 $546.0k60.0k shares
GRAIL INC GRAL GRAL 100 $1.8k100 shares
OPUS GENETICS INC IRD IRD 45 $5345 shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08